These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17426711)

  • 1. An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomas.
    Lam PY; Sia KC; Khong JH; De Geest B; Lim KS; Ho IA; Wang GY; Miao LV; Huynh H; Hui KM
    Mol Ther; 2007 Jun; 15(6):1129-36. PubMed ID: 17426711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Efficient and Safe Herpes Simplex Virus Type 1 Amplicon Vector for Transcriptionally Targeted Therapy of Human Hepatocellular Carcinomas.
    Lam PY; Sia KC; Khong JH; Geest B; Lim KS; Ho IA; Wang GY; Miao L; Huynh H; Hui KM
    Mol Ther; 2007 Jun; 15(6):1129-1136. PubMed ID: 28182922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering an improved cell cycle-regulatable herpes simplex virus type 1 amplicon vector with enhanced transgene expression in proliferating cells yet attenuated activities in resting cells.
    Wang GY; Ho IA; Sia KC; Miao L; Hui KM; Lam PY
    Hum Gene Ther; 2007 Mar; 18(3):222-31. PubMed ID: 17355186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-specific expression of artificial microRNAs targeting essential genes exhibit potent antitumor effect on hepatocellular carcinoma cells.
    Mao C; Liu H; Chen P; Ye J; Teng L; Jia Z; Cao J
    Oncotarget; 2015 Mar; 6(8):5707-19. PubMed ID: 25691059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioma-specific and cell cycle-regulated herpes simplex virus type 1 amplicon viral vector.
    Ho IA; Hui KM; Lam PY
    Hum Gene Ther; 2004 May; 15(5):495-508. PubMed ID: 15144579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
    Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
    Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
    Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suicidal gene therapy in the effective control of primary human hepatocellular carcinoma as monitored by noninvasive bioimaging.
    Sia KC; Huynh H; Chinnasamy N; Hui KM; Lam PY
    Gene Ther; 2012 May; 19(5):532-42. PubMed ID: 21918545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
    Guan M; Rodriguez-Madoz JR; Alzuguren P; Gomar C; Kramer MG; Kochanek S; Prieto J; Smerdou C; Qian C
    Cancer Res; 2006 Feb; 66(3):1620-9. PubMed ID: 16452221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional targeted gene therapy for hepatocellular carcinoma by adenovirus vector.
    Kanai F
    Mol Biotechnol; 2001 Jul; 18(3):243-50. PubMed ID: 11503518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
    Mawatari F; Tsuruta S; Ido A; Ueki T; Nakao K; Kato Y; Tamaoki T; Ishii N; Nakata K
    Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EIIAPA chimeric promoter for tumor specific gene therapy of hepatoma.
    Hsieh YJ; Chen FD; Ke CC; Wang HE; Huang CJ; Hou MF; Lin KP; Gelovani JG; Liu RS
    Mol Imaging Biol; 2012 Aug; 14(4):452-61. PubMed ID: 21796480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
    Ma XJ; Huang R; Kuang AR
    Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for hepatocellular carcinoma based on tumour-selective suicide gene expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoter.
    Cao G; Kuriyama S; Gao J; Nakatani T; Chen Q; Yoshiji H; Zhao L; Kojima H; Dong Y; Fukui H; Hou J
    Eur J Cancer; 2001 Jan; 37(1):140-7. PubMed ID: 11165141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
    Ido A; Nakata K; Kato Y; Nakao K; Murata K; Fujita M; Ishii N; Tamaoki T; Shiku H; Nagataki S
    Cancer Res; 1995 Jul; 55(14):3105-9. PubMed ID: 7541712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrovirus-mediated gene therapy for hepatocellular carcinoma with reversely oriented therapeutic gene expression regulated by alpha-fetoprotein enhancer/promoter.
    Ishikawa H; Nakata K; Mawatari F; Ueki T; Tsuruta S; Ido A; Nakao K; Kato Y; Ishii N; Eguchi K
    Biochem Biophys Res Commun; 2001 Oct; 287(4):1034-40. PubMed ID: 11573968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector.
    Kuroda T; Rabkin SD; Martuza RL
    Cancer Res; 2006 Oct; 66(20):10127-35. PubMed ID: 17047077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of transcriptional targeting strategy for human hepatocellular carcinoma in an orthotopic xenograft mouse model.
    Sia KC; Huynh H; Chung AY; Ooi LL; Lim KH; Hui KM; Lam PY
    Mol Cancer Ther; 2013 Aug; 12(8):1651-64. PubMed ID: 23720769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
    Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M
    Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.